Oncological diagnosis using positron coincidence gamma camera with fluorodeoxyglucose in comparison with dedicated PET
- 31 May 2002
- journal article
- research article
- Published by Oxford University Press (OUP) in The British Journal of Radiology
- Vol. 75 (893) , 409-416
- https://doi.org/10.1259/bjr.75.893.750409
Abstract
The purpose of this study was to compare the utility of a dual-head positron coincidence detection gamma camera (PCD) with that of dedicated positron emission tomography (PET) in the imaging of various malignancies using 18F-fluorodeoxyglucose (FDG). 25 patients with known or suspected malignancies at various sites underwent imaging with both methods, and diagnostic performance on a lesion basis was compared. Tumour lesions were analyzed visually and semi-quantitatively using the ratio of tumour-to-background counts (T/B ratio). FDG PCD and FDG PET visually detected 34 (72.3%) lesions and 37 (78.7%) lesions, respectively. The mean T/B ratio and standard deviation (SD) of FDG PCD was 3.5±3.3, significantly lower than that of FDG PET (8.4±7.1, pp<0.01). Sensitivity between FDG PCD and FDG PET in lesions of more than 2.0 cm diameter showed no statistically significant difference. This study indicates that FDG imaging with a dual-head coincidence detection gamma camera can provide suitable diagnostic performance for lesions greater than 2.0 cm diameter, but performed significantly worse than dedicated PET for lesions smaller than this.Keywords
This publication has 11 references indexed in Scilit:
- Tumour detectability in 2-dimensional and 3-dimensional positron emission tomography using the SET-2400W: a phantom studyNuclear Medicine Communications, 2001
- Accuracy of standardized uptake value measured by simultaneous emission and transmission scanning in PET oncologyNuclear Medicine Communications, 1999
- Oncologic diagnosis with 2-[fluorine-18]fluoro-2-deoxy-D-glucose imaging: dual-head coincidence gamma camera versus positron emission tomographic scanner.Radiology, 1998
- Multi-Energy Imaging in Nuclear OncologyClinical Positron Imaging, 1998
- Positron emission tomography in oncology: General acceptance of its role is overdueCancer, 1996
- Detection of malignancies with SPECT versus PET, with 2-[fluorine-18]fluoro-2-deoxy-D-glucose.Radiology, 1996
- Fluorodeoxyglucose-positron emission tomography in the detection and staging of lung cancer.American Journal of Respiratory and Critical Care Medicine, 1996
- Mediastinal staging of non-small-cell lung cancer with positron emission tomography.American Journal of Respiratory and Critical Care Medicine, 1995
- Triple-head SPECT with 2-[fluorine-18]fluoro-2-deoxy-D-glucose (FDG): initial evaluation in oncology and comparison with FDG PET.Radiology, 1995
- Solitary pulmonary nodules: detection of malignancy with PET with 2-[F-18]-fluoro-2-deoxy-D-glucose.Radiology, 1992